Avanos Medical (AVNS) Profit After Tax (2013 - 2026)
Avanos Medical (AVNS) reported Profit After Tax of $5.1 million for Q1 2026, down 22.73% on a YoY basis from $6.6 million in Q1 2025, and up 492.31% sequentially from -$1.3 million in Q4 2025.
Avanos Medical (AVNS) Profit After Tax (2013 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 14 years of Profit After Tax data on file, last reported at $5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 22.73% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at -$74.4 million (up 80.93% YoY), and the FY2025 full-year result was -$72.9 million, up 81.41% from the prior year.
- Profit After Tax advanced to $5.1 million in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $16.9 million in Q4 2022 to a low of -$402.8 million in Q4 2024.
- A 5-year average of -$24.6 million and a median of $1.8 million in 2024 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 833.33% in 2025, while the deepest fall reached 4366.67% in 2025.
- Tracing AVNS's Profit After Tax over 5 years: stood at $16.9 million in 2022, then slumped by 34.91% to $11.0 million in 2023, then plunged by 3761.82% to -$402.8 million in 2024, then jumped by 99.68% to -$1.3 million in 2025, then jumped by 492.31% to $5.1 million in 2026.
- Business Quant data shows AVNS's Profit After Tax at $5.1 million in Q1 2026, -$1.3 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 170.93 Mn |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | 5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -76.80 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | -402.80 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | -900,000.00 |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | -8.80 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -500,000.00 |
| Dec 31, 2022 | 16.90 Mn |
| Sep 30, 2022 | 15.70 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | 11.50 Mn |
| Sep 30, 2021 | -35.30 Mn |
| Jun 30, 2021 | 38.50 Mn |